Healthcare provider profile · identity verified

Gabrielle Krstevski, MD

Internal Medicine · BRIGHTON, MI · NPI 1861953804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	234	83
Levothyroxine Sodium	Levothyroxine Sodium	128	37
Amlodipine Besylate	Amlodipine Besylate	123	42
Omeprazole	Omeprazole	111	36
Lisinopril	Lisinopril	94	34
Metformin Hcl Er	Metformin Hcl	79	22
Tamsulosin Hcl	Tamsulosin Hcl	79	29
Losartan Potassium	Losartan Potassium	77	30
Rosuvastatin Calcium	Rosuvastatin Calcium	76	25
Eliquis	Apixaban	69	19
Gabapentin	Gabapentin	63	29
Simvastatin	Simvastatin	61	16
Metoprolol Succinate	Metoprolol Succinate	57	19
Albuterol Sulfate Hfa	Albuterol Sulfate	53	29
Duloxetine Hcl	Duloxetine Hcl	52	18
Metoprolol Tartrate	Metoprolol Tartrate	49	13
Trazodone Hcl	Trazodone Hcl	49	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	13
Pravastatin Sodium	Pravastatin Sodium	46	13
Hydrochlorothiazide	Hydrochlorothiazide	45	19
Metformin Hcl	Metformin Hcl	40	17
Fluticasone Propionate	Fluticasone Propionate	35	21
Mounjaro	Tirzepatide	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	13
Carvedilol	Carvedilol	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	suppressed
Bupropion Xl	Bupropion Hcl	30	12
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	29	29
Diazepam	Diazepam	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Ozempic	Semaglutide	27	suppressed
Allopurinol	Allopurinol	25	suppressed
Furosemide	Furosemide	25	14
Ondansetron Odt	Ondansetron	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	11
Pregabalin	Pregabalin	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Atenolol	Atenolol	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Famotidine	Famotidine	17	11
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	11
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Finasteride	Finasteride	16	suppressed
Naltrexone Hcl	Naltrexone Hcl	16	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	16	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Azithromycin	Azithromycin	13	13
Bupropion Hcl	Bupropion Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Prednisone	Prednisone	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Potassium Chloride	Potassium Chloride	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error